Rigel Pharmaceuticals


Market Cap$226.68M

Compare Rigel Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rigel PharmaceuticalsRigel Pharmaceuticals-9.30%77%--1.9
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

0.8% upside

Undervalued by 0.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$226.68 Million
Enterprise Value$223.99 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.14
Outstanding Shares174,369,503
Avg 30 Day Volume869,645


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.28
Price to Sales-
Price to Book Ratio-1.42
Enterprise Value to Revenue1.69
Enterprise Value to EBIT-11.75
Enterprise Value to Net Income-10
Total Debt to Enterprise0.27
Debt to Equity-1.87

Revenue Sources

No data

ESG Score

No data

About Rigel Pharmaceuticals

CEO: Raul Rodriguez